Point-of-care Cholesterol Monitoring Device Market

Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

2018-11-26
REP-GB-7773
252 pages

Home
Market Research Reports
Healthcare, Pharmaceuticals and Medical devices
Point-of-care Cholesterol Monitoring Device Market

An Incisive, In-depth Analysis on the Point Of Care Cholesterol Monitoring Device Market

This study offers a comprehensive, 360 degree analysis on the Point Of Care Cholesterol Monitoring Device market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Point Of Care Cholesterol Monitoring Device market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Request a sample

Ask An Analyst

Request Special Price

Request Methodology

Growing Awareness Regarding the Benefits of Point-of-Care Cholesterol Monitoring Device

The number of deaths due to cardiovascular diseases, and mortality due to risk factors such as excessive alcohol consumption, smoking, hypercholesterolemia, hyperlipidemia and obesity are increasing globally. Inappropriate eating habits add on to high cholesterol levels leading to fetal health problems related with it. Cholesterol is a waxy chemical compound that is vital for normal body function. But high concentration of cholesterol in the body can increase the risk of heart attacks and many other health issues. The new trend of point-of-care cholesterol monitoring is due to the rising awareness among general population regarding the benefits of these devices. Over the past few years, it is observed that governments across the globe are taking initiatives to increase awareness related to health problems specifically cardiovascualr diseases. These factors are surging the demand for point-of-care cholesterol monitoring device for checking high cholesterol levels, which is expected to drive the growth of the global point-of-care cholesterol monitoring device market.

Growing Geriatric Population

Higher lipoprotein level is a major cardiovascular risk factor that increases the occurrence of wide range of diseases in adults. Unhealthy lifestyle is the major factor in the developed and developing countries resulting in high level of cholesterol, which further increases the incidence of cardiovascular diseases. The geriatric population is at major risk of high cholesterol level, which can lead to problems such as arteriosclerosis, cardiac arrest, etc. Regular monitoring of cholestrol levels through cholesterol monitors such as point-of-care cholesterol monitoring devices as well as through HDL cholesterol kits are necessary to adoid sudden cardiac arrest. Thus, the growing geriatric population is expected to increase the demand for point-of-care cholesterol monitoring device over the forecast period.

Shift towards Self-testing

The cholesterol home test devices and kits are convenient and effective for testing the cholesterol level. The point-of-care cholesterol monitoring device help to check the cholesterol level conveniently at home. The point-of-care cholesterol monitoring device displays the result in few minutes. The use of point-of-care cholesterol monitoring device is a cost-effective way, it helps in early detection and reduces the chance of developing further complications. Therefore, the demand for self-testing kits for at home use is growing nowadays.

Evolving Amendments & Stringent Regulatory Scenarios

The stringent government regulations for approval of any new device in the market is one of the major challenges faced by almost all the countries. Certain amendments have been designed by regulatory policies in the recent years to address the lack of standardization in device portfolio. The stringent protocol for device approvals such as licensing, assessing the safety, and inspection are considered to be a time consuming process for the manufacturers. Regulatory issues are impediments to local device manufacturers. The stringent regulatory policies associated with point-of-care cholesterol monitoring device are expected to hamper the growth of the global point-of-care cholesterol monitoring device market.

Competitive Landscape

This section of the report features profiles of key players operating in the point-of-care cholesterol monitoring device market based on their market share, product offerings for point-of-care cholesterol monitoring device, differential strategies, company dashboard and marketing approach. Examples of some of the key players featured in this report include F. Hoffmann-La Roche Ltd., Acon Laboratories, Inc., Abaxis, Inc., Abbott Laboratories, SD Biosensor, Inc., Jant Pharmacal Corporation, DiaSys Diagnostic Systems GmbH, Bioptik Ltd., and Fitech UK Ltd., among others. These companies offer a wide range of point-of-care cholesterol monitoring device and testing kits. The emerging players operating in the point-of-care cholesterol monitoring device market are majorly focusing on new marketing strategies in order to expand their product footprint in the global point-of-care cholesterol monitoring device market.

Definition

Point-of-care cholesterol monitoring device is used for rapid detection of blood analytes for rapid diagnosis & management. It is a modern-day device that enables the user to perform diagnostic test outside the laboratory. The device is small and portable used to obtain results of blood cholesterol & lipoprotein levels. The device detects total cholesterol profile, including HDL, LDL & Triglycerides. It comes in two types, namely Bench-top and Hand-held devices.

About the Report

The report offers a comprehensive evaluation of the business opportunities in the point-of-care cholesterol monitoring device market along with insights that elaborate the macroeconomic factors influencing the dynamics of the point-of-care cholesterol monitoring device market, and its futuristic potential.

Segmentation

The report offers a comprehensive taxonomy of the point-of-care cholesterol monitoring device market on the basis of product type, technology, application, end user and region. On the basis of product type, the global point-of-care cholesterol monitoring device market has been segmented into point-of-care cholesterol monitoring device instruments and testing kits. On the basis of technology, the global point-of-care cholesterol monitoring device market has been segmented into electrochemical biosensor and reflectance photometry. On the basis of application, the point-of-care cholesterol monitoring device market is segmented as dyslipidemia, arteriosclerosis, hypercholesterolemia, hypocholesterolemia and others. Geographically, the point-of-care cholesterol monitoring device market has been segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding China and Japan, China, Japan and Middle East & Africa (MEA).

Additional Questions Answered

Some of the additional questions addressed in this report on point-of-care cholesterol monitoring device market-

What is the revenue potential of point-of-care cholesterol monitoring device market across regions of North America and Europe?
Who are the key competitors in the point-of-care cholesterol monitoring device market and what are their portfolios?
What are the major challenges influencing the growth of the point-of-care cholesterol monitoring device market?
How is intervention from regulatory authorities shaping the point-of-care cholesterol monitoring device market growth?

Research Methodology

The point-of-care cholesterol monitoring device market has been estimated based on the supply-demand approach. A triangulation methodology is adopted to derive the point-of-care cholesterol monitoring device market size, which is primarily based on overall expenditure on capital equipment installed base , life science research and R&D funding to obtain precise market estimations and insights on life science and biotechnology associated services , products, technologies and applications. This information is further validated with rigorous primary research (including interviews, surveys, in-person interactions, and viewpoints of seasoned analysts) and secondary research (including verified paid sources, authentic trade journals, and resourceful databases).

A recent market study published by the company “Point-of-care Cholesterol Monitoring Device Market: Global Industry Analysis 2013–2017 & Opportunity Assessment 2018–2028” consists a comprehensive assessment of the most important market dynamics. On conducting a comprehensive research on the historic as well as current growth parameters of the point-of-care cholesterol monitoring device market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that are likely to have a high impact on the development of the point-of-care cholesterol monitoring device market during the forecast period. It can help the players operating in the market to modify their manufacturing and marketing strategies to envisage maximum growth in the point-of-care cholesterol monitoring device market in the upcoming years. The report provides detailed information about the current and future growth prospects of the point-of-care cholesterol monitoring device market in the most comprehensive manner for the better understanding of readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the point-of-care cholesterol monitoring device market, which includes the summary of key findings and key statistics of the point-of-care cholesterol monitoring device market. It also includes the market value (US$ million) estimates of the leading segments of the point-of-care cholesterol monitoring device market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and definition of the point-of-care cholesterol monitoring device market in this chapter, which will help them understand the basic information about the point-of-care cholesterol monitoring device market dynamics, opportunity analysis, list of key distributors & suppliers, list of key market participants, epidemiology study, and pipeline assessment.

Chapter 3 – North America Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

This chapter includes a detailed analysis of the growth of the North America point-of-care cholesterol monitoring device market along with a country-wise assessment that includes the U.S. and Canada. Readers can also find market growth and market attractiveness analysis based on product type, technology, application, end user and countries in the North America market.

Chapter 4 – Latin America Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

Readers can find detailed information about the growth of the Latin America point-of-care cholesterol monitoring device market. This chapter also includes the growth prospects of the point-of-care cholesterol monitoring device market in leading LATAM countries such as Brazil, Mexico and the Rest of Latin America.

Chapter 5 – Western Europe Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

Important growth prospects of the point-of-care cholesterol monitoring device market based on its product type and distribution channel in several Western European countries, such as Germany, the U.K., France, Italy, Spain and Rest of Western Europe, are included in this chapter.

Chapter 6 – Eastern Europe Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

Important growth prospects of the point-of-care cholesterol monitoring device market based on product type and distribution channel in several Eastern European countries, such as Russia, Poland and Rest of Eastern Europe, are included in this chapter.

Chapter 7 – Asia Pacific excluding China & Japan Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

India, ASEAN, Australia and New Zealand and Rest of APECJ are the leading countries in the APECJ region, which are the prime subjects of assessment to obtain the growth prospects of the APECJ point-of-care cholesterol monitoring device market in this chapter. Readers can find detailed information about the growth parameters of the APECJ point-of-care cholesterol monitoring device market during the period 2018–2028.

Chapter 8 – China Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

This chapter provides information on how the point-of-care cholesterol monitoring device market will grow in China during the period 2018–2028.

Chapter 9 – Japan Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

This chapter provides information on how the point-of-care cholesterol monitoring device market will grow in Japan during the period 2018–2028.

Chapter 10 – Middle East & Africa (MEA) Point-of-care Cholesterol Monitoring Device Market Analysis (2013–2017) & Opportunity Assessment (2018–2028)

This chapter provides information about how the point-of-care cholesterol monitoring device market will grow in the major countries in the MEA region, such as GCC Countries, South Africa and the Rest of MEA.

Chapter 11 – Competition Landscape and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the Point-of-care cholesterol monitoring device market along with detailed information about each company, including company overview, revenue shares, strategic overview and recent company developments. Market players featured in this report include Acon Laboratories, Inc., F.Hoffmann-La Roche Ltd., Samsung Healthcare, Abbott Laboratories, SD Biosensor, Inc., DiaSys Diagnostic Systems GmbH, Jant Pharmacal Corporation, Bioptik Ltd., and General Life Biotechnology Co., Ltd., among others.

Chapter 12 – Global Point-of-care Cholesterol Monitoring Device Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Product Type

Based on the product type, the point-of-care cholesterol monitoring device market is segmented into point-of-care cholesterol monitoring device instruments and testing kits. In this chapter, readers can find information about the key trends and developments in the point-of-care cholesterol monitoring device market and market attractive analysis based on the product type as well as region-wise product offerings.

Chapter 13 – Global Point-of-care Cholesterol Monitoring Device Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By End User

Based on the end user, the point-of-care cholesterol monitoring device market is segmented into hospital, diagnostic centers & laboratory, ambulatory surgical centers and home care settings. In this chapter, readers can find information about the key trends and developments in the point-of-care cholesterol monitoring device market and market attractive analysis based on the end user for each region.

Chapter 14 – Global Point-of-care Cholesterol Monitoring Device Market Analysis 2013–2017 & Opportunity Assessment 2018–2028, By Region

This chapter explains how the point-of-care cholesterol monitoring device market will grow across various geographic regions, which include North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China & Japan (APECJ), China, Japan and the Middle East & Africa (MEA).

Chapter 15 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 16 – Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, important qualitative information and quantitative information about the point-of-care cholesterol monitoring device market.